Pages that link to "Q38826141"
The following pages link to Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function (Q38826141):
Displaying 50 items.
- Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine (Q28076397) (← links)
- Inherited heart disease - what can we expect from the second decade of human iPS cell research? (Q28079217) (← links)
- Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. (Q33906188) (← links)
- Anisotropic engineered heart tissue made from laser-cut decellularized myocardium. (Q36116195) (← links)
- Muscle-on-chip: An in vitro model for donor-host cardiomyocyte coupling. (Q38479111) (← links)
- Cardiac spheroids as promising in vitro models to study the human heart microenvironment. (Q38647934) (← links)
- Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes (Q38731678) (← links)
- Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? (Q38819976) (← links)
- Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease (Q38850545) (← links)
- Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity. (Q38910479) (← links)
- Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. (Q39345477) (← links)
- Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies (Q41664792) (← links)
- IGF1 and NRG1 Enhance Proliferation, Metabolic Maturity, and the Force-Frequency Response in hESC-Derived Engineered Cardiac Tissues (Q41690530) (← links)
- Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes (Q41700317) (← links)
- Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems (Q46096606) (← links)
- Force Generation via β-Cardiac Myosin, Titin, and α-Actinin Drives Cardiac Sarcomere Assembly from Cell-Matrix Adhesions (Q47188823) (← links)
- MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo. (Q47241525) (← links)
- A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes (Q47315861) (← links)
- Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (Q47703951) (← links)
- Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation. (Q49886497) (← links)
- Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells (Q49923296) (← links)
- A Recipe for T-Tubules in Human iPS Cell-Derived Cardiomyocytes (Q50021170) (← links)
- Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes. (Q50022359) (← links)
- Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes. (Q50420944) (← links)
- Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation. (Q55039464) (← links)
- Concise Review: The Current State of Human in vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering (Q57292609) (← links)
- Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review (Q57465354) (← links)
- Systems-Wide Approaches in Induced Pluripotent Stem Cell Models (Q58086434) (← links)
- Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research (Q60303926) (← links)
- MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo (Q64075653) (← links)
- Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes (Q89170102) (← links)
- Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes (Q90197028) (← links)
- The cell surface marker CD36 selectively identifies matured, mitochondria-rich hPSC-cardiomyocytes (Q90208449) (← links)
- Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload (Q90254876) (← links)
- Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Usi (Q90289902) (← links)
- Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells (Q90352365) (← links)
- A cardiomyocyte show of force: A fluorescent alpha-actinin reporter line sheds light on human cardiomyocyte contractility versus substrate stiffness (Q90602626) (← links)
- Everolimus Rescues the Phenotype of Elastin Insufficiency in Patient Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells (Q90655331) (← links)
- Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment (Q90955485) (← links)
- Cardiac tissue engineering: state-of-the-art methods and outlook (Q91811749) (← links)
- Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes (Q91975109) (← links)
- Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy (Q92251744) (← links)
- A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology (Q92396924) (← links)
- Direct Sarcomere Modulators Are Promising New Treatments for Cardiomyopathies (Q92441606) (← links)
- Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes (Q92480289) (← links)
- Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy (Q92709167) (← links)
- Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism (Q92895912) (← links)
- Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies (Q93140938) (← links)
- Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy (Q93230241) (← links)
- Simple Workflow and Comparison of Media for hPSC-Cardiomyocyte Cryopreservation and Recovery (Q99589742) (← links)